Poster Abstract Session:
55. HAI: Multi Drug Resistant Gram Negatives
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Trainee, Epidemiology and Infection Control, Adult ID

Presentations:
315
A Qualitative Study of Infection Prevention Perceptions, Beliefs, and Practices in the Emergency Department
Stephen Liang, MD, MPHS ; Katherine Brown, MPH ; Jennifer Williams, PhD, RN, ACNS-BC ; Josephine Fox, RN, MPH ; David K. Warren, MD, MPH, FIDSA, FSHEA ; Aimee James, PhD, MPH
317
Clinical Characteristics of a Military Trauma Cohort with Stenotrophomonas maltophilia Infection
Shane Patterson, M.D. ; Katrin Mende, PhD ; Ping Li, MS ; Dan Z. Lu, MS ; Clinton K. Murray, MD, FIDSA ; David Tribble, MD, DrPH, FIDSA ; Dana M. Blyth, M.D.
318
Burden and risk factors of multi-drug resistant gram-negative organisms in Veterans with spinal cord injury
Charlesnika Evans, PhD, MPH ; Margaret Fitzpatrick, MD, MS ; Linda Poggensee, MS ; Swetha Ramanathan, MPH ; Sherri Lavela, PhD MPH MBA ; Stephen Burns, MD ; Makoto Jones, MD, MS ; Katie J. Suda, PharmD, M.S.
Posters
  • Evans 10-16final.pdf (785.4 kB)
  • 319
    Outcome of Initial Antibiotic Treatments among Hospitalized Patients with Hospital- and Healthcare-Associated Bacterial Infections in Brazil: Findings of the RECOMMEND Study
    Sudeep Karve, PhD ; Kellie Ryan, MPH ; Esther Pascual, PhD ; Pascale Peeters, MD ; Sonia Rojas-Farreras, MSc ; Elisa Baelen, MSc ; Jesus Rodriguez-Bano, MD
    321
    Acinetobacter baumannii Infection Among Critically Ill Cancer Patients In Intensive Care Settings In Pakistan: A Case-Control Comparison Of Risk Factors And Outcomes
    Aun Raza, MBBS, FCPS ; Amjad Mahboob, MBBS, FCPS ; Faisal Sultan, MD, DABIM, DABID, FRCP ; Sayed Hammad Nazeer, MD, DABIM, DABID ; Irfaan Mobein, Mbbs ; Waleed Zafar, Mbbs.MPH.
    322
    Understanding the Role of Host Human Products on the Acquisition of Resistance Traits through Natural Transformation in Acinetobacter baumannii. 
    Brettni Quinn, BS ; German Matias Traglia, MS ; Meaghan Nguyen, Undergraduate Student ; Alonso Soler Bistue, PhD ; Maria Soledad Ramirez, PhD-Assistant professor
    323
    Measuring the Prevalence of Multidrug Resistant Acinetobacter (MDRA) Using OXA 23 and OXA 51 Gene Identification in Healthcare Facilities (HCF) in Washington DC
    Jacqueline Reuben, MHS ; Nancy Donegan, MPH ; Jo Anne Nelson, DC ; Brendan Sinatro, MPH ; Morris Blaylock, Ph.D. ; Kimary Harmon, MBA, MPH
    Posters
  • 323 IDWkMDRA.pdf (734.3 kB)
  • 325
    Prevalence of Multi-Drug Resistant Organisms (MDROs) Using an Antibiotic Resistant Gene Assay at a Tertiary Care Center
    Joseph Timpone, M.D. ; Rebecca Kumar, M.D. ; Deepa Lazarous, M.D. ; Seble Kassaye, MD, MS ; Puneet Agarwal, M.D. ; Roshni Biswas, MBBS, MPH ; Amanda Finnell, BS ; Mary Mcfadden, R.N., MHA ; Princy Kumar, M.D.
    326
    Stenotrophomonas maltophilia Resistance in Military Trauma Patients
    Shane Patterson, M.D. ; Katrin Mende, PhD ; Ping Li, MS ; Dan Z. Lu, MS ; Clinton K. Murray, MD, FIDSA ; David R. Tribble, MD, DrPH, FIDSA ; Dana M. Blyth, M.D.
    Posters
  • Micro steno ID Week poster.pdf (487.1 kB)
  • 327
    Trends in Gram-negative Bloodstream Isolates with Limited High-efficacyLow-toxicity Antibiotic Options among Inpatients at 180 US Hospitals
    Alicen B. Spaulding, PhD, MPH ; Yi Ling Lai, MPH ; Jennifer Adjemian, PhD ; D. Rebecca Prevots, PhD, MPH ; Tara Palmore, MD ; Chanu Rhee, MD, MPH ; Michael Klompas, MD, MPH, FRCPC, FIDSA ; John P. Dekker, M.D., Ph.D. ; Anthony Suffredini, MD ; David C. Hooper, MD ; Scott Fridkin, MD, FIDSA ; Robert L. Danner, MD ; Sameer S. Kadri, MD, MS.
    328
    Trends in Multidrug Resistant Bacteria and Clostridium difficile in an Integrated Healthcare Network, 2008-2015
    Bert K. Lopansri, MD ; Dominika Swistun, PhD candidate ; Rajesh Mehta, RPh, MS ; Brandon Webb, MD ; Edward Stenehjem, MD, MSc ; Michelle Keane, BS, MBA ; David Pombo, MD ; Kristin Dascomb, MD, PhD ; John Burke, MD, FIDSA, FSHEA
    329
    Development of a Regional Antibiogram to Monitor Burden and Distribution of MDRO Pathogens Across the Spectrum of Care in Los Angeles County
    Jessica Silvaggio, MPH ; Dawn Terashita, MD, MPH ; Patricia Marquez, MPH, CIC ; Annemarie Flood, RN, BSN, MPH, CIC ; Job Mendez, RN, MD ; James a. Mckinnell, MD
    330
    Molecular Epidemiology and Outcomes of Carbapenem Non-Susceptible (CARB-NS) Clinical Isolates in Detroit
    Michael Veve, PharmD ; Jeremy Delor, PharmD student ; Robert Tibbetts, Ph.D. D(ABMM), F(CCM) ; Susan L Davis, PharmD
    Posters
  • veve_molEpi_outcomes.pdf (284.3 kB)
  • 332
    An Analysis of Carbapenem-Sensitive and Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates Obtained in Stony Brook University Hospital
    Elizabeth Diago-Navarro, PhD ; Kaarina I. Hanington, Undergraduate student ; Aisha Khan, D.O, MPH ; Mutayyaba Adnan, Undergraduate student ; Hyun Ah Yoon, MD ; Eric Spitzer, M.D., Ph.D. ; Bettina Fries, MD, FIDSA
    333
    Impact of expanded Carbapenem Resistant Enterobacteriacae (CRE) screening on Rates of Hospital Acquired (HA) CRE infection
    Catherine Passaretti, MD ; Anupama Neelakanta, MD ; Monica Schmidt, MPH, PhD ; Joanne Sitaras, BSN
    Posters
  • CRE_ID_WEEK poster.pdf (138.4 kB)
  • 334
    Risk Factor and Outcome Evaluation in Patients with Carbapenem Resistant Enterobacteriaceae (CRE) in a Mid-Western Tertiary Care Academic Medical Center
    Madhuri Sopirala, MD, MPH ; Francis Ssali, MD ; Siyun Liao, Pharm.D., PhD, BCPS ; Loretta Simbartl, MS ; Stephen Kralovic, MD, MPH, FSHEA
    336
    Epidemiology of the emergence of Carbapenemase-producing Enterobacteriaceae in South-central Ontario, Canada
    Philipp Kohler, MD ; Roberto Melano, PhD ; Samir N. Patel, PhD, FCCM ; Shumona Shafinaz, MD ; Amna Faheem, MD ; Brenda L. Coleman, PhD ; Karen Green, MSc ; Irene Armstrong, MD, MSc ; Huda Almohri, BSc, MD, FRCPC ; Kevin Katz, MD, CM, MSc, FRCPC ; Freda Lam, MPH, CPHI(C) ; Matthew Muller, MD, PhD ; Jeff Powis, MD, MSc, FRCPC ; Susan Poutanen, MD, MPH ; David Richardson, MD ; Laura Rosella, PhD ; Anu Rebbapragada, PhD ; Alicia Sarabia, MD ; Andrew Simor, MD ; Allison Mcgeer, MD, MSc
    Posters
  • CPE_Poster_12Oct2016.pdf (277.2 kB)
  • 338
      Carbapenem-Resistant Enterobacteriaceae (CRE) and Antimicrobial Usage within the Veterans Affairs (VA) Healthcare System: 2010-2014
    Russell Ryono, Pharm. D. ; Gina Oda, MS ; Patricia Schirmer, MD ; Cynthia Lucero-Obusan, MD ; Mark Holodniy, MD, FIDSA, FSHEA
    340
    A comprehensive, intensive patient surveillance program for carbapenemase-producing bacteria at the NIH Clinical Center
    Robin T. Odom, M.S. ; Amanda M. Ramsburg, B.S.N. ; Anna F. Lau, Ph.D. ; John P. Dekker, M.D., Ph.D. ; Angela V. Michelin, M.P.H. ; Mary Ann Bordner, M.S. ; David K. Henderson, M.D. ; Karen M. Frank, M.D., Ph.D. ; Tara N. Palmore, MD
    342
    Recurrence of Positive Cultures for Carbapenem-resistant Enterobacteriaceae (CRE) in Atlanta
    Mary Elizabeth Sexton, MD ; Chris Bower, MPH ; Jesse T. Jacob, MD
    Posters
  • Recurrence Poster.pdf (471.6 kB)
  • 343
    What's Lurking Around the Corner: Identifying Novel CRE Resistance Mechanisms in the Los Angeles County Healthcare Community, 2015
    Patricia Marquez, MPH, CIC ; Nicole Green, PhD, D(ABMM) ; Dawn Terashita, MD, MPH ; Sandeep Bhaurla, MPH ; Laurene Mascola, MD, MPH
    Posters
  • IDWeek_CREtestingLAC.pdf (261.7 kB)
  • 344
    Assessing Carbapenemase Resistant Enterobacteriaceae (CRE) Prevalence Using a Combined Antibiotic Resistance Gene Assay and Surveillance Cultures in Hospitalized Patients
    Rebecca Kumar, M.D. ; Princy Kumar, M.D. ; Deepa Lazarous, M.D. ; Puneet Agarwal, M.D. ; Roshni Biswas, MBBS, MPH ; Seble Kassaye, MD, MS ; Allen Chao, BS, MS ; Kelly Wang, BS ; Amanda Finnell, BS ; Mary Mcfadden, R.N., MHA ; Joseph Timpone, M.D.
    345
    Colonization with Carbapenem-Resistant Enterobacteriaceae (CRE) Increases the Risk of Bloodstream Infections with CRE
    Rossana Rosa, MD ; Jose Castro, MD, FIDSA ; Dennise Depascale, MT ; Adriana Jimenez, MPH, MLS (ASCP), CIC. ; L. Silvia Munoz-Price, MD, PhD
    Posters
  • CRE_IDW16_poster.pdf (618.1 kB)
  • 348
    Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage at the Time of Admission Using a State-Wide Hospital Discharge Database
    Michael Y. Lin, MD, MPH ; Serena Rezny, MS ; Michael J. Ray, MPH ; Dejan Jovanov, BSc ; Robert A. Weinstein, MD ; William E. Trick, MD
    349
    Posters
  • Slide1.GIF (1.2 MB)
  • 350
    Surveillance for Carbapenem-Resistant Pseudomonas aeruginosa at Five U.S. Sites – 2015
    Maroya Spalding Walters, PhD ; Sandra Bulens, MPH ; Emily B. Hancock, MS ; Erin C. Phipps, DVM, MPH ; Daniel Muleta, MD, MPH ; Jacquelyn Mounsey, BSN, RN, CCRP ; Marion Kainer, MBBS, MPH, FSHEA ; Cathleen Concannon, MPH ; Ghinwa Dumyati, MD, FSHEA ; Chris Bower, MPH ; Jesse T. Jacob, MD ; P. Maureen Cassidy, MPH ; Zintars G. Beldavs, MS ; Uzma Ansari, MS ; Valerie Albrecht, MPH ; Maria S. Karlsson, PhD ; J. Kamile Rasheed, PhD ; Alexander Kallen, MD, MPH
    352
    National Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in the Ambulatory and Acute Care Settings in the United States in 2015
    Holly Hoffman-Roberts, PharmD ; Melanie Olesky, PhD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS
    Posters
  • Tetraphase CRE 352 10-21-16.pdf (208.4 kB)
  • 353
    A Cluster of Carbapenemase-Producing Enterobacter cloacae ST171 at a Tertiary Care Center Demonstrating an Ongoing Regional Threat
    Edwin C Pereira, MD ; Melissa Hargreaves, PhD ; Jeana Houseman, MHSA, DLM(ASCP), CIC ; Timothy Johnson, PhD ; Ruth Lynfield, MD, FIDSA ; Paula Snippes Vagnone, MT (ASCP) ; Medora Witwer, MPH ; Susan Kline, MD, MPH, FSHEA
    Posters
  • IDWeek poster - PEREIRA.pdf (272.0 kB)
  • 357
    Incomplete Adoption of Clinical Laboratory Standards Institute (CLSI) Breakpoints to Detect Carbapenem Resistant Organisms
    James a. Mckinnell, MD ; Janet Hindler, MCLS, MT(ASCP) ; Erin Epson, MD ; Sam Horwich-Scholefield, MPH, CIC ; Loren Miller, MD, MPH ; Job Mendez, RN, MD ; Jeremias Martinez, BS ; Jacob Sinkowitz, HSD ; Dawn Terashita, MD, MPH ; Patricia Marquez, MPH, CIC ; Sandeep Bhaurla, MPH ; Marcelo Moran, MA, MPH ; Lindsey Pandes, MPH ; Christina Hershey, BA ; Romney Humphries, PhD
    358
    blaVIM-producing Enterobacter cloacae in Ontario, Canada: Links between Sewage, Surface Water, and Human Isolates
    Philipp Kohler, MD ; Hyunjin Kim, BSc ; Roberto Melano, PhD ; Jennie Johnstone, MD ; Samir Patel, PhD ; Nathalie Tijet, PhD ; Barbara Willey, ART ; Brenda Coleman, PhD ; Karen Green, MSc ; Irene Armstrong, MD, MSc ; Kevin Katz, MD, CM, MSc, FRCPC ; Matthew P. Muller, MD, PhD, FRCPC ; Jeff Powis, MD, MSc, FRCPC ; Susan Poutanen, MD, MPH ; David Richardson, MD ; Alicia Sarabia, MD ; Andrew E. Simor, MD, FRCPC, FACP ; Allison Mcgeer, MD, MSc
    Posters
  • VIM_Poster_12Oct2016.pdf (361.2 kB)
  • 359
    Emerging Waves of Carbapenem Resistance among Gram-negative Pathogens at a Tertiary Center
    Ryan K. Shields, PharmD ; Lloyd Clarke, BScHons ; Julie Paronish, MPH ; Cornelius J. Clancy, MD ; Minh-Hong Nguyen, MD
    360
    Pseudomonas aeruginosa Non-susceptibility to Common Antibiotics by Source in USA Hospitals in 2015: A Multicenter Study
    Sanjay Merchant, PhD ; Ying P. Tabak, PhD ; C. Andrew Deryke, PharmD ; Daryl D. Depestel, PharmD, BCPS-ID ; Richard S Johannes, MD, MS ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS
    361
    Multidrug Resistant Pseudomonas aeruginosa (MDR-PSA) in USA Hospitals by Geographic Region in 2015
    C. Andrew Deryke, PharmD ; Daryl D. Depestel, PharmD, BCPS-ID ; Ying P. Tabak, PhD ; Sanjay Merchant, PhD ; Richard S Johannes, MD, MS ; John Jay Hawkshead III, DrPH ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS
    362
    Carbapenem-resistant Gram-negative Pathogens among Hospitalized Patients in the United States between 2010 and 2015
    Bin Cai, MD, MPH, MS, PhD ; Roger Echols, MD, FIDSA ; Gareth Morgan, Ph.D ; Juan Camilo Arjona Ferreira, MD ; Mari Ariyasu, Ph.D ; Takuko Sawada, BA ; Tsutae Den Nagata, MD, PhD, FFPM
    Posters
  • 362_IDWPOSTER.pdf (788.4 kB)
  • 363
    Impact of Institutional Carbapenem Usage on Pseudomonas aeruginosa Resistance
    Tara Lindeman, Pharm.D. ; Travis W. Linneman, Pharm.D. ; Ryan P. Moenster, Pharm.D.
    365
    Regional Difference of Extended-spectrum β-lactamases (ESBLs) Susceptibility in USA Hospitals in 2015 
    Daryl D. Depestel, PharmD, BCPS-ID ; Ying P. Tabak, PhD ; C. Andrew Deryke, PharmD ; Sanjay Merchant, PhD ; Richard S Johannes, MD, MS ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS
    366
    Sites of Colonization in Hospitalized Patients with Infections Caused by Extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella pneumoniae
    Zeina Kanafani, MD ; Sukayna Fadlallah, MS ; Sarah Assaf, MD ; Khalil Anouti, MD ; Kohar Annie Kissoyan, MS ; Jad Sfeir, MD ; Tamara Nawar, MD ; Mohamad Yasmin, MD ; Ghassan Matar, PhD
    Posters
  • Poster.pdf (849.6 kB)
  • 367
    The Predictive Utility of Screening ESBL Swabs in Selecting Empiric Antibiotics for Sterile-Site Infections
    Ian Brasg, MD ; Marion Elligsen, RPh ; Derek Macfadden, MD ; Nick Daneman, MD, MSc
    Posters
  • IDWeek 2016 ESBL Oct 23.pdf (281.6 kB)
  • 369
    National Prevalence of Extended Spectrum Beta-lactamase Producing Enterobacteriaceae (ESBL) in the Ambulatory and Acute Care Settings in the United States in 2015
    Holly Hoffman-Roberts, PharmD ; Katherine Luepke, PharmD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS
    370
    Antibiotic Resistance and Clinical Presentation of Healthcare-associated Hypervirulent Klebsiella pneumoniae Infection
    Hyun Ah Kim, M.D., Ph.D ; Miri Hyun, MD ; Hyo-Lim Hong, MD ; Hyun Hee Kwon, MD, Ph.D ; Seong Yeol Ryu, M.D., Ph.D
    371
    Bacteremia due to Escherichia coli with the plasmid-mediated colistin resistance (COL-R) mcr-1 gene
    Andrea Vila, MD ; Cynthia V Rivero, MD ; Mariana Chumbita, resident ; Juan Ignacio Dapás, MD ; Hugo Pagella, Bioquemistry ; Fernando Pasterán, Bioquemistry ; Alejandra Corso, Bioquemistry
    Posters
  • mcr1.pdf (4.6 MB)
  • 373
    Surveillance for Multidrug-Resistant Gram-negative Bacilli: Use of Selective Screening Agar Increases the Rate of Detection and Decreases Cost of Screening
    Ishminder Kaur, M.D. ; Jennifer Vodzak, MD ; Kaushik Patel, MT ; Sarah S. Long, MD ; Jane M. Gould, MD ; Alan T. Evangelista, PhD
    Posters
  • VACC Poster Kaur 36X60.pdf (828.4 kB)
  • 374
    Temporal trends in Ceftriaxone resistant Escherichia coli infections
    Sumanth Rajagopal, MD ; G.Thomas Ray, MBA ; Roger Baxter, MD, FIDSA
    Posters
  • 374, IDWEEK 2016.pdf (310.4 kB)
  • 375
    Characteristics and Predictive Factors for Multidrug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients
    Wesley Campbell, MD ; Ping Li, MS ; Timothy Whitman, DO ; Dana M. Blyth, M.D. ; Elizabeth Schnaubelt, MD ; Katrin Mende, PhD ; David R. Tribble, MD, DrPH, FIDSA
    376
    Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin-Resistant Infections caused by Enterobacteriaceae Species Other than Escherichia coli and Klebsiella pneumoniae
    Amanda Adler, BA ; Xuan Qin, PhD ; Scott Weissman, MD ; Matthew Kronman, MD, MSCE ; Arianna Miles-Jay, MPH ; Carey-Ann D. Burnham, PhD ; Alexis Elward, MD, MPH, FSHEA ; Jason Newland, MD, MEd, FPIDS ; Rangaraj Selvarangan, PhD ; Kaede V. Sullivan, MD ; Theoklis Zaoutis, MD, MSCE ; Danielle Zerr, MD, MPH, FPIDS
    Posters
  • IDSA_poster_10_18_16.pdf (766.6 kB)
  • 378
    National Prevalence of Multidrug-Resistance (MDR) in Enterobacteriaceae (ENT) in the Ambulatory and Acute Care Settings in the United States in 2015
    Hina Patel, PharmD ; Holly Hoffman-Roberts, PharmD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS
    Posters
  • MDR ENT 378 10-24-16.pdf (362.8 kB)
  • 379
    Prevalence and Risk Factors of a Novel Piperacillin/Tazobactam-Non-Susceptible, β-lactam-Pan-Susceptible (TZP-NS/BL-PS) Phenotype in Enterobacteriaceae
    Abrar Thabit, PharmD, BCPS ; Joseph Kuti, PharmD ; Jaber Aslanzadeh, PhD ; David Nicolau, PharmD, FCCP, FIDSA
    Posters
  • TZP NS_ID Week Poster.pdf (119.4 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.